Inception Return
(11/20/2001)
|
2.67 %
|
|
YTD Return
|
-4.69 %
|
|
NAVPS
(5/14/2026)
|
$18.69
|
|
Change
|
$0.00 / -0.02 %
|
|
|
Growth of $10,000
(As of April 30, 2026)
|
|
MER
|
3.20 %
|
|
Assets ($mil)
|
$26.46
|
|
Rank (1Yr)
|
65/76
|
|
Std Dev (3Yr)
|
15.69 %
|
|
Volatility Ranking (3Yr)
|
8/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
-
|
|
Max Back End
|
5.00 %
|
|
Sales Status
|
Open
|
|
|
Objective
The investment objective of the fund is to provide above-average long-term capital growth by investing primarily in publicly traded American common stocks in long-term growth sectors/industries of the market.
|
Fund Manager
GLC Asset Management Group Ltd.
Portfolio Manager
London Life Insurance Co.
Sub-Advisor
-
|
|
Asset Allocation
(As of April 30, 2026)
|
Sector Allocation
(As of April 30, 2026)
|
Geographic Allocation
(As of April 30, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| DexCom Inc | US Equity | Healthcare | United States | 4.25% |
| Jack Henry & Associates Inc | US Equity | Technology | United States | 4.21% |
| Keysight Technologies Inc | US Equity | Industrial Goods | United States | 4.16% |
| Cirrus Logic Inc | US Equity | Technology | United States | 4.01% |
| Akamai Technologies Inc | US Equity | Technology | United States | 3.90% |
| Generac Holdings Inc | US Equity | Industrial Goods | United States | 3.86% |
| Align Technology Inc | US Equity | Healthcare | United States | 3.79% |
| HealthEquity Inc | US Equity | Technology | United States | 3.62% |
| Charles River Laboratories Intl Inc | US Equity | Healthcare | United States | 3.47% |
| Bio-Techne Corp | US Equity | Healthcare | United States | 3.43% |
Performance Data
(As of April 30, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
0.23
|
-4.91
|
-3.85
|
-4.69
|
8.44
|
4.48
|
0.05
|
7.05
|
|
Benchmark
|
5.98
|
6.92
|
9.79
|
8.77
|
31.06
|
17.03
|
9.32
|
11.81
|
|
Quartile Ranking
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
-1.85
|
12.86
|
9.94
|
-20.58
|
24.09
|
13.81
|
23.92
|
-5.85
|
14.53
|
1.19
|
|
Benchmark
|
7.19
|
24.39
|
13.76
|
-11.77
|
20.00
|
11.78
|
21.65
|
-2.87
|
8.66
|
14.08
|
|
Quartile Ranking
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
4
|